Higher 36 mg dose of orforglipron leads to 12.4% weight loss vs 0.9% for placebo Dropout rate due to side effects was about 10% for high-dose patients Lilly plans to file for approval of once-daily ...
Eli Lilly said on Tuesday its experimental GLP-1 pill helped overweight adults with type 2 diabetes shed 10.5% of body weight in a late-stage trial, after recent data from another study of the drug in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback